Filitra is a prescription medication classified as a phosphodiesterase type 5 inhibitor used primarily for the treatment of erectile dysfunction. Its therapeutic purpose is to improve erectile response by enhancing blood flow to the penis during sexual stimulation. The active ingredient works by binding to the enzyme phosphodiesterase type 5 in smooth muscle cells. This binding blocks the enzyme's activity which normally breaks down cyclic guanosine monophosphate. Inhibition of the enzyme leads to increased levels of cyclic guanosine monophosphate in the corpus cavernosum. Elevated cyclic guanosine monophosphate causes relaxation of smooth muscle and dilation of blood vessels. The resulting vascular changes allow more blood to fill the erectile tissue. This physiological effect produces a firm and sustained erection sufficient for satisfactory sexual activity.

Filitra is a phosphodiesterase type 5 inhibitor used to treat erectile dysfunction in men. It functions by enhancing the natural physiological response to sexual stimulation through increased blood flow to the penis. The drug works by blocking the enzyme phosphodiesterase type 5 that normally degrades cyclic guanosine monophosphate. This inhibition leads to accumulation of cyclic guanosine monophosphate which relaxes smooth muscle cells. The resulting vasodilation improves erectile function and supports sustained sexual activity. Pharmacodynamically Filitra reverses the degradation of a messenger molecule that controls vascular tone. Its pharmacological profile includes rapid absorption oral bioavailability and a duration of action that supports typical sexual encounters. Overall the medication targets a specific pathway to facilitate the physiological process necessary for achieving and maintaining an erection.

The most frequently observed side effects of the medication include mild headache and occasional nausea. Some individuals may experience temporary fatigue that usually resolves without intervention. A small proportion report mild digestive discomfort that tends to fade over time. Dizziness can occur especially when standing up quickly but it often improves with gradual adjustments. Skin reactions such as mild redness or itching have been noted in occasional cases. Most of these effects are short lived and typically do not cause concern.

The most common side effects reported with many medications include mild fatigue and occasional headache. Some patients also experience temporary nausea or a slight loss of appetite. Mild dizziness may occur, especially when standing up quickly. Skin reactions such as a brief rash or itching are occasionally observed. Digestive disturbances like mild diarrhea or constipation are also frequent. In many cases these effects are short-lived and resolve without intervention. Understanding these typical reactions helps patients recognize normal occurrences.